Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka

Clin Mol Hepatol. 2023;29(4):851-868. Published online March 9, 2023

DOI: https://doi.org/10.3350/cmh.2022.0434

View: 6815 Download: 353 Web of Science: 7 Crossref: 9

Hyeji Kim, Jung Hyun Kwon, Yong Hee Kim, Soon Woo Nam, Jong Yul Lee, Jeong Won Jang

Clin Mol Hepatol. 2018;24(4):430-435. Published online November 27, 2017

DOI: https://doi.org/10.3350/cmh.2017.0016

View: 8124 Download: 233 Web of Science: 2 Crossref: 2

Venessa Pattullo

Clin Mol Hepatol. 2016;22(2):219-237. Published online June 13, 2016

DOI: https://doi.org/10.3350/cmh.2016.0024

View: 16724 Download: 651 Web of Science: 81 Crossref: 83

Suang Min Lim , Jeong Won Jang , Byung Wook Kim , Hwang Choi , Kyu Yong Choi , Soo Jeong Park , Chi Wha Han

Clin Mol Hepatol. 2008;14(2):213-218. Published online June 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.2.213

View: 4573 Download: 46 Crossref: 6

1 |

Viewed By 5561	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4769	MAFLD: How is it different from NAFLD?
Viewed By 4500	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3680	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3658	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 135	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 80	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Search